Board announce CEO stands down

ADMIN
Fri, Apr 08 2022 10:38 am

8 April 2022

Board Announcement

In response to the company’s FY22 interim result, the Board of Vital Limited (NZX: VTL) wishes to provide shareholders with an early update related to its ongoing review of the company’s performance.

The Board’s current focus is on Vital’s operational structure to identify and implement sustained cost savings capable of supporting a return to profitability, as early as practicable.

In line with this direction the Board wishes to advise that Vital’s chief executive officer, Andrew Miller, will stand down from his role effective 8 April 2022.

Mr Miller has been working with the Board through this early stage and it has been agreed that the time was right for a change in direction and structure in the role of the CEO going forward.

The Board wishes to acknowledge Mr Miller’s significant contribution to Vital during his five years leading the company.

Jason Bull will be the company’s acting chief executive officer, effective from the date of Mr Miller’s departure, whist the company works to appoint a permanent CEO.

The Board will continue to advise shareholders of all material actions being taken in relation to its performance review process. It also expects to provide a comprehensive overview of the process and actions at the company’s full year results announcement later this year.

ENDS

For further information, please contact:

Roger Sowry
Chairman
+64 27 445 5753


Announcement PDF


Markets News

Fisher & Paykel Healthcare helps NZX up 1%
Markets Market Close

Fisher & Paykel Healthcare helps NZX up 1%

Skellerup Holdings shares rose 5.1%. 

Gregor Thompson 01 Jul 2025
Retail

Warehouse drops guidance, loss now in scope

The retailer has raised the possibility of a full-year earnings loss.

Gregor Thompson 01 Jul 2025
Warehouse drops guidance, loss now in scope
Markets Analysis

Xero’s Melio ‘leap of faith’

The NZ-founded company’s giant-killer dreams in the US hinge on this huge bet. 

Pattrick Smellie 01 Jul 2025
Xero’s Melio ‘leap of faith’